| scholarly article | Q13442814 |
| P2093 | author name string | Evgeny Edovitsky | |
| Eyal Zcharia | |||
| Michael Elkin | |||
| Tamar Peretz | |||
| Israel Vlodavsky | |||
| Immanuel Lerner | |||
| P2860 | cites work | Human heparanase. Purification, characterization, cloning, and expression | Q22003728 |
| Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis | Q22010222 | ||
| Heparanase mediates cell adhesion independent of its enzymatic activity | Q24303492 | ||
| Processing and activation of latent heparanase occurs in lysosomes | Q24338680 | ||
| Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis | Q24630993 | ||
| A system for stable expression of short interfering RNAs in mammalian cells | Q27860875 | ||
| Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis | Q28138868 | ||
| Cloning and functional expression of a human heparanase gene | Q28139582 | ||
| Heparanase expression in primary and metastatic pancreatic cancer | Q28201783 | ||
| Heparanases and tumor metastasis | Q28294717 | ||
| Macromolecular organization of basement membranes | Q28297954 | ||
| Heparanase regulates murine hair growth | Q28511958 | ||
| MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data | Q29547902 | ||
| Functions of cell surface heparan sulfate proteoglycans | Q29618521 | ||
| Basement membranes: structure, assembly and role in tumour angiogenesis | Q29622882 | ||
| Extracellular matrix moieties, cytokines, and enzymes: dynamic effects on immune cell behavior and inflammation. | Q33835592 | ||
| Delayed type hypersensitivity: current theories with an historic perspective | Q33836893 | ||
| Molecular properties and involvement of heparanase in cancer progression and normal development | Q34088794 | ||
| Cell surface expression and secretion of heparanase markedly promote tumor angiogenesis and metastasis | Q34098843 | ||
| Heparanase: a key enzyme involved in cell invasion | Q34183747 | ||
| A disaccharide that inhibits tumor necrosis factor alpha is formed from the extracellular matrix by the enzyme heparanase | Q34285445 | ||
| Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis | Q34328744 | ||
| Endothelium in vitro: a review of human vascular endothelial cell lines for blood vessel-related research | Q34503665 | ||
| Degradation of heparan sulfate in the subendothelial extracellular matrix by a readily released heparanase from human neutrophils. Possible role in invasion through basement membranes | Q34557357 | ||
| Suppression of experimental autoimmune diseases and prolongation of allograft survival by treatment of animals with low doses of heparins | Q34567626 | ||
| The complete sequence of perlecan, a basement membrane heparan sulfate proteoglycan, reveals extensive similarity with laminin A chain, low density lipoprotein-receptor, and the neural cell adhesion molecule | Q34620069 | ||
| Syndecans in inflammation | Q35094731 | ||
| Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation | Q35382754 | ||
| Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucosa and stroma. Evidence for its role in colonic tumorigenesis | Q35745865 | ||
| Extracellular sequestration and release of fibroblast growth factor: a regulatory mechanism? | Q37407186 | ||
| Permanent cell line expressing human factor VIII-related antigen established by hybridization | Q37615209 | ||
| Inhibition of tumor metastasis by heparanase inhibiting species of heparin. | Q38313060 | ||
| Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents | Q39799215 | ||
| Heparanase accelerates wound angiogenesis and wound healing in mouse and rat models. | Q40464583 | ||
| Inflammatory cytokines and fatty acids regulate endothelial cell heparanase expression | Q40562955 | ||
| Regulation of heparanase gene expression by estrogen in breast cancer. | Q40604115 | ||
| Proteoglycans of basement membranes | Q40910738 | ||
| Proteoglycans of the extracellular environment: clues from the gene and protein side offer novel perspectives in molecular diversity and function | Q40981990 | ||
| Soluble antigen induces T lymphocytes to secrete an endoglycosidase that degrades the heparan sulfate moiety of subendothelial extracellular matrix | Q43769417 | ||
| The role of IFN-gamma in delayed-type hypersensitivity mediated by Th1 clones | Q44317052 | ||
| Undersulfated and glycol-split heparins endowed with antiangiogenic activity | Q44754685 | ||
| Transgenic expression of mammalian heparanase uncovers physiological functions of heparan sulfate in tissue morphogenesis, vascularization, and feeding behavior | Q44760488 | ||
| Inhibition of T lymphocyte heparanase by heparin prevents T cell migration and T cell-mediated immunity | Q44887841 | ||
| Effect of locally administered heparins on delayed-type hypersensitivity reactions | Q44896345 | ||
| Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splitting | Q45221614 | ||
| Enhanced delivery of naked DNA to the skin by non-invasive in vivo electroporation | Q45888962 | ||
| Microarray analysis of primary endothelial cells challenged with different inflammatory and immune cytokines | Q46629210 | ||
| Expression pattern and secretion of human and chicken heparanase are determined by their signal peptide sequence | Q48362166 | ||
| Heavy functions for light chains. | Q52011907 | ||
| Vascular endothelial cells in cell-mediated immunity: adoptive transfer with in vitro conditioned cells is genetically restricted at the endothelial cell barrier. | Q54281478 | ||
| Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis. | Q54705410 | ||
| Evidence that sulphated polysaccharides inhibit tumour metastasis by blocking tumour-cell-derived heparanases | Q69423635 | ||
| Lymphoma cell-mediated degradation of sulfated proteoglycans in the subendothelial extracellular matrix: relationship to tumor cell metastasis | Q70986448 | ||
| Inhibition of delayed-type hypersensitivity by heparin depleted of anticoagulant activity | Q71097183 | ||
| Comparative analysis of the ability of leucocytes, endothelial cells and platelets to degrade the subendothelial basement membrane: evidence for cytokine dependence and detection of a novel sulfatase | Q72349595 | ||
| Processing of the human heparanase precursor and evidence that the active enzyme is a heterodimer | Q73066556 | ||
| Heparanase as mediator of angiogenesis: mode of action | Q74101720 | ||
| Heparanase protein and gene expression in bladder cancer | Q74486083 | ||
| Heparanase-1 expression is associated with the metastatic potential of breast cancer | Q74758098 | ||
| The pure antiestrogen ICI 182,780 inhibits progestin-induced transcription | Q77931882 | ||
| [Studies on hypersensitivity. I. Demonstration and description of an increase of vascular permeability in the tuberculin hypersensitivity reactions] | Q79701133 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| P304 | page(s) | 3609-3616 | |
| P577 | publication date | 2005-12-29 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Role of endothelial heparanase in delayed-type hypersensitivity | |
| P478 | volume | 107 |
| Q38656697 | A novel method to identify hub pathways of rheumatoid arthritis based on differential pathway networks |
| Q28389931 | Bacillus anthracis' lethal toxin induces broad transcriptional responses in human peripheral monocytes |
| Q39259358 | Berberine inhibits the migration and invasion of T24 bladder cancer cells via reducing the expression of heparanase |
| Q37505173 | Blood vessels pattern heparan sulfate gradients between their apical and basolateral aspects |
| Q33331276 | Cathepsin L is responsible for processing and activation of proheparanase through multiple cleavages of a linker segment |
| Q45977912 | Chronological changes of delayed-type hypersensitivity in mice immunised with testicular germ cells alone. |
| Q36462810 | Clinical significance of urine heparanase in bladder cancer progression |
| Q36853911 | Coexpression of heparanase activity, cathepsin L, tissue factor, tissue factor pathway inhibitor, and MMP-9 in proliferative diabetic retinopathy |
| Q40324623 | Decorin potentiates interferon-γ activity in a model of allergic inflammation |
| Q30492454 | Dynamic alterations in chemokine gradients induce transendothelial shuttling of human T cells under physiologic shear conditions |
| Q38814469 | Endothelial glycocalyx breakdown is mediated by angiopoietin-2. |
| Q37380225 | Expression of heparanase in basal cell carcinoma and squamous cell carcinoma |
| Q37720528 | Extracellular matrix hyaluronan signals via its CD44 receptor in the increased responsiveness to mechanical stimulation |
| Q91798106 | Forty Years of Basic and Translational Heparanase Research |
| Q33747297 | Genetic variations in the heparanase gene (HPSE) associate with increased risk of GVHD following allogeneic stem cell transplantation: effect of discrepancy between recipients and donors |
| Q40147443 | Heart in sepsis : Molecular mechanisms, diagnosis and therapy of septic cardiomyopathy |
| Q58585910 | Heparan Sulfate Mimetics in Cancer Therapy: The Challenge to Define Structural Determinants and the Relevance of Targets for Optimal Activity |
| Q38116039 | Heparan sulfate inhibitors and their therapeutic implications in inflammatory illnesses |
| Q35059448 | Heparan sulfate proteoglycans |
| Q39138407 | Heparanase 1 involvement in prostate physiopathology. |
| Q37413886 | Heparanase and autoimmune diabetes. |
| Q37194268 | Heparanase augments epidermal growth factor receptor phosphorylation: correlation with head and neck tumor progression |
| Q37983752 | Heparanase enzyme in chronic inflammatory bowel disease and colon cancer |
| Q53371446 | Heparanase expression by Barrett's epithelium and during esophageal carcinoma progression. |
| Q35855109 | Heparanase expression in circulating lymphocytes of breast cancer patients depends on the presence of the primary tumor and/or systemic metastasis |
| Q44008453 | Heparanase expression in periapical granulomas and radicular cysts |
| Q38080632 | Heparanase in inflammation and inflammation-associated cancer |
| Q36953862 | Heparanase induces VEGF C and facilitates tumor lymphangiogenesis |
| Q46634692 | Heparanase induces inflammatory cell recruitment in vivo by promoting adhesion to vascular endothelium |
| Q37500036 | Heparanase interacts with resistin and augments its activity |
| Q34473624 | Heparanase is a host enzyme required for herpes simplex virus-1 release from cells |
| Q33761544 | Heparanase is preferentially expressed in human psoriatic lesions and induces development of psoriasiform skin inflammation in mice |
| Q36143598 | Heparanase levels are elevated in the plasma of pediatric cancer patients and correlate with response to anticancer treatment |
| Q81473187 | Heparanase prevents the development of type 1 diabetes in non-obese diabetic mice by regulating T-cell activation and cytokines production |
| Q33564445 | Heparanase promotes engraftment and prevents graft versus host disease in stem cell transplantation |
| Q28264895 | Heparanase regulates thrombosis in vascular injury and stent-induced flow disturbance |
| Q38985052 | Heparanase regulation of cancer, autophagy and inflammation: new mechanisms and targets for therapy |
| Q79241944 | Heparanase upregulation by colonic epithelium in inflammatory bowel disease |
| Q90183482 | Heparanase-2 protects from LPS-mediated endothelial injury by inhibiting TLR4 signalling |
| Q42587945 | Heparanase: From basic research to therapeutic applications in cancer and inflammation |
| Q38801721 | Heparanase: a rainbow pharmacological target associated to multiple pathologies including rare diseases |
| Q36752653 | Heparanase: a target for drug discovery in cancer and inflammation |
| Q39120713 | Heparanase: roles in cell survival, extracellular matrix remodelling and the development of kidney disease |
| Q37105310 | Heparin and related drugs: beyond anticoagulant activity. |
| Q36919158 | Impact of heparanase and the tumor microenvironment on cancer metastasis and angiogenesis: basic aspects and clinical applications |
| Q59329666 | Inflammation and lung injury in an ovine model of fluid resuscitated endotoxemic shock |
| Q41024376 | Intestinal anti-inflammatory activity of Ground Cherry (Physalis angulata L.) standardized CO2 phytopharmaceutical preparation. |
| Q37486713 | Inverse correlation between HPSE gene single nucleotide polymorphisms and heparanase expression: possibility of multiple levels of heparanase regulation |
| Q35636604 | Involvement of Heparanase in Empyema: Implication for Novel Therapeutic Approaches |
| Q40057329 | Low and high affinity receptors mediate cellular uptake of heparanase |
| Q34652072 | Mammalian heparanase: what is the message? |
| Q52845977 | Microbial metabolites and derivatives targeted at inflammation and bone diseases therapy: chemistry, biological activity and pharmacology. |
| Q33714011 | Modification of heparanase gene expression in response to conditioning and LPS treatment: strong correlation to rs4693608 SNP. |
| Q53179295 | Non Melanoma Skin Cancer Pathogenesis Overview. |
| Q91798207 | Non-Anticoagulant Heparins as Heparanase Inhibitors |
| Q58573663 | Novel Insights Into the Role of Glycans in the Pathophysiology of Glomerular Endotheliosis in Preeclampsia |
| Q38855728 | Old and new applications of non-anticoagulant heparin |
| Q42291940 | Overexpression of heparanase enhances T lymphocyte activities and intensifies the inflammatory response in a model of murine rheumatoid arthritis |
| Q42224130 | Phosphomannopentaose sulfate (PI-88) suppresses angiogenesis by downregulating heparanase and vascular endothelial growth factor in an oxygen-induced retinal neovascularization animal model. |
| Q39572643 | Reactive oxygen species mediate high glucose-induced heparanase-1 production and heparan sulphate proteoglycan degradation in human and rat endothelial cells: a potential role in the pathogenesis of atherosclerosis |
| Q46305715 | Regulation and function of endothelial glycocalyx layer in vascular diseases |
| Q36101233 | Significance of heparanase in cancer and inflammation |
| Q92137106 | Targeting Heparanase in Cancer: Inhibition by Synthetic, Chemically Modified, and Natural Compounds |
| Q47207922 | The Role of Heparan Sulfate in Inflammation, and the Development of Biomimetics as Anti-Inflammatory Strategies. |
| Q35850606 | The Synthetic Antimicrobial Peptide 19-2.5 Interacts with Heparanase and Heparan Sulfate in Murine and Human Sepsis |
| Q36452903 | The potential of heparanase as a therapeutic target in cancer |
| Q36569379 | The role of heparan sulphate in inflammation |
| Q35651533 | The role of heparanase in pulmonary cell recruitment in response to an allergic but not non-allergic stimulus |
| Q91682933 | Transcriptomic analysis reveals cell apoptotic signature modified by heparanase in melanoma cells |
| Q42650601 | Vascular endothelial growth factor c/vascular endothelial growth factor receptor 3 signaling regulates chemokine gradients and lymphocyte migration from tissues to lymphatics |
| Q33770777 | Versatile role of heparanase in inflammation |
Search more.